The value of a two-armed Bayesian response adaptive randomization trial

References

• Azriel, D., M. Mandel, and Y. Rinott. 2012. Optimal allocation to maximize the power of two-sample tests for binary response. Biometrika 99 (1):101–113. doi:10.1093/biomet/asr077.
   Web of Science ®Google Scholar
• Berry, S.M., B.P. Carlin, J.J. Lee, and P. Mueller. 2010. Bayesian adaptive methods for clinical trials. Boca Raton, FL, USA: Chapman & Hall.
   Google Scholar
• Brown, A.R., B.J. Gajewski, L.S. Aaronson, D.P. Mudaranthakam, S.L. Hunt, S.M. Berry, M. Quintana, M. Pasnoor, M.M. Dimachkie, O. Jawdat, et al. 2016. A Bayesian comparative effectiveness trial in action: Developing a Platform for multi-site study adaptive randomization. Trials 17 (1):428. doi:10.1186/s13063-016-1544-5.
   PubMedGoogle Scholar
• Carlson, S.E., J. Colombo, B.J. Gajewski, K.M. Gustafson, D. Mundy, J. Yeast, M.K. Georgieff, L.A. Markley, E.H. Kerling, and D.J. Shaddy. 2013. DHA supplementation and pregnancy outcomes. The American Journal of Clinical Nutrition 97 (4):808–815. doi:10.3945/ajcn.112.050021.
   PubMed Web of Science ®Google Scholar
• Carlson, S.E., B.J. Gajewski, S. Alhayek, J. Colombo, E.H. Kerling, and K.M. Gustafson. 2018. Dose-response relationship between Docosahexaenoic Acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 138:1–5. doi:10.1016/j.plefa.2018.09.002.
   PubMed Web of Science ®Google Scholar
• Carlson, S.E., B.J. Gajewski, C.J. Valentine, L.K. Rogers, C.P. Weiner, D.O. DeFranco, and C.S. Buhimschi. 2017. Assessment of DHA on reducing early preterm birth: The ADORE randomized controlled trial protocol. BMC Pregnancy and Childbirth 17 (1):62. doi:10.1186/s12884-017-1244-5.
   PubMedGoogle Scholar
• Carlson, G., K. Valentine, C. Weiner, R. Buhimschi, B. Sands, C. Mudaranthakam, Buhimschi, C. S. DeFranco, L. K. Rogers, S. A. Sands, et al. 2021. Higher dose docosahexaenoic acid supplementation during pregnancy reduces early preterm birth: A randomised, double-blind, adaptive-design superiority trial. EClinicalMedicine: A Publication by the Lancet 36:100905. doi:10.1016/j.eclinm.2021.100905.
   PubMedGoogle Scholar
• Gajewski, B.J., S.M. Berry, M. Quintana, M. Pasnoor, M. Dimachkie, L. Herbelin, and R. Barohn. 2015. Building Efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: Finding the sweet spot. Statistics in Medicine 34 (7):1134–1149. doi:10.1002/sim.6403.
   PubMed Web of Science ®Google Scholar
• Gajewski, B.J., C.S. Reese, J. Colombo, and S. Carlson. 2016. Commensurate priors on a finite mixture model for incorporating repository data in clinical trials. Statistics in Biopharmaceutical Research 8 (2):151–160. doi:10.1080/19466315.2015.1133453.
   PubMed Web of Science ®Google Scholar
• Gajewski, B., S. Simon, and S. Carlson. 2008. Predicting accrual in clinical trials with bayesian posterior predictive distributions. Statistics in Medicine 27 (13):2328–2340. doi:10.1002/sim.3128.
   PubMed Web of Science ®Google Scholar
• Gajewski, S., Statland, J. Barohn, and R. Barohn. 2019. Using adaptive designs to avoid selecting the wrong arms in multi-arm comparative effectiveness trials. Statistics in Biopharmaceutical Research 11 (4):375–386. doi:10.1080/19466315.2019.1610044.
   PubMed Web of Science ®Google Scholar
• Hey, S., and J. Kimmelman. 2015. Are outcome-adaptive allocation trials ethical? Clinical Trials 12 (2):102–106. doi:10.1177/1740774514563583.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., G. Guarino, S. Ma, S. Simon, M.S. Mayo, R. Raghavan, and B.J. Gajewski. 2016. Bayesian accrual prediction for interim review of clinical studies: Open source R package and smart phone application. Trials 17 (1):336. doi:10.1186/s13063-016-1457-3.
   PubMedGoogle Scholar
• Jiang, F., J.L. Jack, and P. Muller. 2013. A Bayesian decision-theoretic sequential response-adaptive randomization design. Statistics in Medicine 32 (12):1975–1994. doi:10.1002/sim.5735.
   PubMed Web of Science ®Google Scholar
• Makrides, M., K. Best, L. Yelland, A. McPhee, S. Zhou, J. Quinlivan, J. Dodd, E. Atkinson, H. Safa, J. van Dam, et al. 2019. A randomized trial of Prenatal n−3 fatty acid supplementation and preterm delivery. The New England Journal of Medicine. 381(11):1035–1045. doi:10.1056/NEJMoa1816832.
   PubMed Web of Science ®Google Scholar
• Mudaranthakam, D., A. Brown, E. Kerling, S. Carlson, C. Valentine, and B. Gajewski. 2021. The Successful Synchronized Orchestration of an Investigator-Initiated Multicenter Trial Using a Clinical Trial Management System and Team Approach. Design and Utility Study JMIR Form Res 5 (12):e30368. doi:10.2196/30368.
   PubMedGoogle Scholar
• Simmonds, L.A., T.R. Sullivan, M. Skubisz, P.F. Middleton, K.P. Best, L.N. Yelland, J. Quinlivan, S.J. Zhou, G. Liu, A.J. McPhee, et al. 2020. Omega‐3 fatty acid supplementation in pregnancy—baseline omega‐3 status and early preterm birth: Exploratory analysis of a randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology 127 (8):975–981. doi:10.1111/1471-0528.16168.
   PubMed Web of Science ®Google Scholar
• Unger, J.M., C.D. Blanke, M. LeBlanc, and D.L. Hershman. 2020. Association of the Coronavirus disease 2019 (COVID-19) outbreak with enrollment in cancer clinical trials. JAMA Network Open 3 (6):e2010651. doi:10.1001/jamanetworkopen.2020.10651.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). (2019), Adaptive designs for clinical trials of drugs and biologics guidance for industry.
   Google Scholar
• Viele, K., K. Broglio, A. McGlothlin, and B.R. Saville. 2020. Comparison of methods for control allocation in multiple arm studies using response adaptive randomization. Clinical Trials 17 (1):52–60. doi:10.1177/1740774519877836.
   PubMed Web of Science ®Google Scholar
• Wick, J., S.M. Berry, H. Yeh, W. Choi, C.M. Pacheco, C. Daley, and B.J. Gajewski. 2017. A novel evaluation of optimality for randomized controlled trials. Journal of Biopharmaceutical Statistics 27 (4):659–672. doi:10.1080/10543406.2016.1198367.
   PubMed Web of Science ®Google Scholar
• Yelland, L., B. Gajewski, J. Colombo, R. Gibson, M. Makrides, and S. Carlson. 2016. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 112:44–49. doi:10.1016/j.plefa.2016.08.007.
   PubMed Web of Science ®Google Scholar